Peptide Nucleic Acid as Therapeutic Agent
With a repeating N-(2-aminoethyl)-glycine peptide backbone coupled to purine and pyrimidine nucleobases via a linker, PNA are synthetic analogues of DNA. PNA-based technology has received a lot of interest as a viable method for gene modification due to the unique qualities of PNA, including resistance to enzymatic digestion, increased bio stability, and excellent hybridization affinity toward DNA and RNA. However, inadequate intracellular absorption presents a significant obstacle to the use of PNA. To improve PNA delivery and ensure that it reaches the appropriate spot, some solutions have been devised
Related Conference of Peptide Nucleic Acid as Therapeutic Agent
Peptide Nucleic Acid as Therapeutic Agent Conference Speakers
Recommended Sessions
- A New Approach to Determining the Nucleic Acid Sequence
- Function of Nucleic Acid
- Types of RNA
- Artificial Nucleic Acid
- DNA Damage and Repair
- Effect of Nucleic Acid on Protein Synthesis
- Enzymes for Nucleic Acids
- Infectious Disease
- Molecular Biology
- Molecular Structure of Nucleic Acid
- Nucleic Acid as a Genetic Material
- Nucleic Acid Bases
- Nucleic Acid Probes
- Nucleic Acid Recognition
- Peptide Nucleic Acid as Therapeutic Agent
- Recombinant DNA Technology
- RNA Processing and Protein Synthesis
- Thermodynamics of Nucleic Acids